Effects of Combined Treatment with Angiotensin II Type 1 Receptor Blocker and Statin on Stent Restenosis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  2009-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/FJC.0b013e318199f30bPMID 19188828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Impact of a combined treatment of angiotensin II type 1 receptor blockade and 3-hydroxy-3-methyl-glutaryl-CoA-reductase inhibition on secretory phospholipase A2-type IIA and low density lipoprotein oxidation in patients with coronary artery disease.

  2008cited by this paper
• Effect of Fluvastatin and Valsartan, Alone and in Combination, on Postprandial Vascular Inflammation and Fibrinolytic Activity in Patients With Essential Hypertension

  2007cited by this paper
• Comparison of cardiovascular events in patients with angiographically documented coronary narrowing with combined renin-angiotensin system inhibitor plus statin versus renin-angiotensin system inhibitor alone versus statin alone (from the Japanese Coronary Artery Disease Study).

  2007cited by this paper
• Effects of Statins on Restenosis After Coronary Stent Implantation

  2007cited by this paper
• Carvedilol Inhibits Proliferation of Cultured Pulmonary Artery Smooth Muscle Cells of Patients with Idiopathic Pulmonary Arterial Hypertension

  2006cited by this paper
• Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: a randomized study with intravascular ultrasound.

  2005cited by this paper
• Renin-Angiotensin System Intervention to Prevent In-Stent Restenosis: An Unclosed Chapter

  2005cited by this paper
• Prednisolone Inhibits Proliferation of Cultured Pulmonary Artery Smooth Muscle Cells of Patients With Idiopathic Pulmonary Arterial Hypertension

  2005cited by this paper
• 3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes.

  2004cited by this paper
• Fluvastatin Enhances the Inhibitory Effects of a Selective Angiotensin II Type 1 Receptor Blocker, Valsartan, on Vascular Neointimal Formation

  2003cited by this paper
• The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation.

  2002cited by this paper
• Valsartan Therapy Has Additive Anti-oxidative Effect to That of Fluvastatin Therapy Against Low-Density Lipoprotein Oxidation: Studies in Hypercholesterolemic and Hypertensive Patients

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• The AT1-Type Angiotensin Receptor in Oxidative Stress and Atherogenesis

  2002cited by this paper
• The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis.

  2002cited by this paper
• The p53-activated Gene, PAG608, Requires a Zinc Finger Domain for Nuclear Localization and Oxidative Stress-induced Apoptosis*

  2002cited by this paper
• Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.

  2001cited by this paper
• Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial.

  2001cited by this paper
• HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen Species

  2001cited by this paper
• Effect of statin therapy on restenosis after coronary stent implantation.

  2000cited by this paper
• Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells.

  1999cited by this paper
• Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells.

  1999cited by this paper
• Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system.

  1999cited by this paper
• Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects.

  1999cited by this paper
• Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men.

  1999cited by this paper
• Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II.

  1998cited by this paper
• Beta3-integrins rather than beta1-integrins dominate integrin-matrix interactions involved in postinjury smooth muscle cell migration.

  1998cited by this paper
• β3-Integrins Rather Than β1-Integrins Dominate Integrin-Matrix Interactions Involved in Postinjury Smooth Muscle Cell Migration

  1998cited by this paper
• Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression.

  1997cited by this paper
• Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells.

  1997cited by this paper
• Endothelial Function and Oxidant Stress

  1997cited by this paper
• Signalling mechanisms in the regulation of vascular cell migration.

  1995cited by this paper
• Comparison of accuracy and precision of quantitative coronary arterial analysis between cinefilm and digital systems

  1994cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper

• An overview of in-stent restenosis in iliofemoral venous stents.

  2021cites this paper
• Atheroprotective effects of statins in patients with unstable angina by regulating the blood-borne microRNA network

  2017cites this paper
• In stent restenosis after percutaneous coronary intervention

  2016cites this paper
• BMSCs Interactions with Adventitial Fibroblasts Display Smooth Muscle Cell Lineage Potential in Differentiation and Migration That Contributes to Neointimal Formation

  2016cites this paper
• Renin–angiotensin system inhibitors in patients with coronary artery disease who have undergone percutaneous coronary intervention

  2016cites this paper
• The Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Postangioplasty Restenosis.

  2015cites this paper
• Original Article Effects of hydroxysafflor yellow A on proliferation and collagen synthesis of rat vascular adventitial fibroblasts induced by angiotensin II

  2014cites this paper
• Effects of BMSCs interactions with adventitial fibroblasts in transdifferentiation and ultrastructure processes.

  2014cites this paper
• Effects of hydroxysafflor yellow A on proliferation and collagen synthesis of rat vascular adventitial fibroblasts induced by angiotensin II.

  2014cites this paper
• Differential Metabolic Actions of Specific Statins: Clinical and Therapeutic Considerations

  2014cites this paper
• Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.

  2013cites this paper
• Controlling the Proliferation and Differentiation Stages to Initiate Periodontal Regeneration

  2013cites this paper
• Treatment B) Drug Therapy

  2013cites this paper
• The effects of low-dose fluvastatin and valsartan combination on arterial function: a randomized clinical trial.

  2012cites this paper
• Neointimal Hyperplasia Inhibition Effect of Angiotensin II Type 1 Receptor Blockers in Patients after Coronary Stent Implantation

  2011cites this paper
• Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement.

  2011cites this paper
• Inhibitory Effects of Simvastatin on Platelet-derived Growth Factor Signaling in Pulmonary Artery Smooth Muscle Cells From Patients With Idiopathic Pulmonary Arterial Hypertension

  2010cites this paper
• 4-Hydroxy-2-nonenal induces calcium overload via the generation of reactive oxygen species in isolated rat cardiac myocytes.

  2009cites this paper
• Chronic angiotensin-(1-7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-beta/Smad signaling pathway in rabbits.

  2009cites this paper